文献速递慢性肾脏病血液净化与透析

共同设计的肾脏与糖尿病整合照护模式改善死亡率、血糖控制与自我管理

A co-designed integrated kidney and diabetes model of care improves mortality, glycaemic control and self-care.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

该纵向分析纳入糖尿病合并慢性肾脏病(CKD)3a-5期成人患者,比较接受糖尿病与肾脏病服务(DKS)整合干预(n=196)与标准照护(n=7511)的差异。结果显示DKS组全因死亡率更低(IRR 0.4),住院率更高但住院时间更短,自我管理及他汀使用、眼足检查改善,HbA1c在3、6、9、12个月分别下降0.40%、0.35%、0.34%、0.23%,eGFR无显著变化。

要点

  • DKS整合照护可降低糖尿病合并CKD患者全因死亡率(IRR 0.4)。
  • DKS组住院率更高但中位住院时间更短(2天 vs 4天)。
  • DKS改善自我管理、他汀使用及眼足检查,并持续降低HbA1c。

核心结论

  • 共同设计的以患者为中心的整合照护模式改善了糖尿病合并CKD患者的全因死亡率、肾功能、血糖控制及自我管理。

主要发现

  • DKS组住院率高于标准照护组,IRR 1.20(95%CI 1.13-1.30),P<0.0001。
  • DKS组中位住院时间2天(IQR 1-6),短于标准照护组的4天(IQR 1-9),P<0.0001。
  • DKS组全因死亡率低于标准照护组,IRR 0.4(95%CI 0.29-0.64),P<0.0001。
  • 12个月时总体自我管理评分平均差异2.26(95%CI 0.83-3.69),P<0.001,他汀使用及眼、足检查亦有改善。
  • 随访3、6、9、12个月HbA1c分别显著下降0.40%、0.35%、0.34%、0.23%;12个月eGFR平均差异1.30 mL/min/1.73 m2(95%CI -4.17-1.67),P=0.40,无显著变化。

临床怎么用

  • 对糖尿病合并CKD 3a-5期患者,可考虑采用共同设计的多学科整合照护模式以降低死亡风险并改善血糖控制与自我管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current healthcare models are ill-equipped for managing people with diabetes and chronic kidney disease (CKD). We evaluated the impact of a new diabetes and kidney disease service (DKS) on hospitalization, mortality, clinical and patient-relevant outcomes. METHODS: Longitudinal analyses of adult patients with diabetes and CKD (Stages 3a-5) were performed using outpatient and hospitalization data from January 2015 to October 2018. Data were handled according to whether patients received the DKS intervention (n = 196) or standard care (n = 7511). The DKS provided patient-centred, coordinated multidisciplinary assessment and management of patients. Primary analyses examined hospitalization and mortality rates between the two groups. Secondary analyses evaluated the impact of the DKS on clinical target attainment, changes in estimated glomerular filtration rate (eGFR), glycated haemoglobin A1c (HbA1c), self-care and patient activation at 12 months. RESULTS: Patients who received the intervention had a higher hospitalization rate {incidence rate ratio [IRR] 1.20 [95% confidence interval (CI) 1.13-1.30]; P < 0.0001}, shorter median length of stay {2 days [interquartile range (IQR) 1-6] versus 4 days [IQR 1-9]; P < 0.0001} and lower all-cause mortality rate [IRR 0.4 (95% CI 0.29-0.64); P < 0.0001] than those who received standard care. Improvements in overall self-care [mean difference 2.26 (95% CI 0.83-3.69); P < 0.001] and in statin use and eye and feet examinations were observed. The mean eGFR did not change significantly after 12 months [mean difference 1.30 mL/min/1.73 m2 (95% CI -4.17-1.67); P = 0.40]. HbA1c levels significantly decreased by 0.40, 0.35, 0.34 and 0.23% at 3, 6, 9 and 12 months of follow-up, respectively. CONCLUSIONS: A co-designed, person-centred integrated model of care improved all-cause mortality, kidney function, glycaemic control and self-care for patients with diabetes and CKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Zimbudzi E, Lo C, Ranasinha S, et al. A co-designed integrated kidney and diabetes model of care improves mortality, glycaemic control and self-care. Nephrol Dial Transplant. 2022. PMID: 34314493. doi:10.1093/ndt/gfab230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。